Form 4 AI
Back to all filings

Form 4 · Filed Jul 28, 2026, 01:36 AM UTC

UTHR/UNITED THERAPEUTICS Corp

ROTHBLATT MARTINE A — Chairperson & CEO

AI Thesis

A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.

Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.

Transactions

11 rows
DateCodeDirectionSharesPriceValueOwned after
Jul 27, 2026Mother9,500$135$1,286,490333,943
Jul 27, 2026Ssell680$526$357,552333,263
Jul 27, 2026Ssell890$527$469,152332,373
Jul 27, 2026Ssell650$529$343,530331,723
Jul 27, 2026Ssell1,797$530$951,959329,926
Jul 27, 2026Ssell1,121$530$594,675328,805
Jul 27, 2026Ssell1,836$532$976,107326,969
Jul 27, 2026Ssell1,529$532$814,004325,440
Jul 27, 2026Ssell957$534$510,590324,483
Jul 27, 2026Ssell40$535$21,402324,443
Jul 27, 2026Mother9,500265,410

Source: SEC EDGAR raw filing ↗ · Accession 0001106578-26-000107

UTHR Form 4 — ROTHBLATT MARTINE A — Form 4 AI